$OMCL

Njoku Nnamdi sold $114K of OMCL

Njoku Nnamdi (President & COO) sold 3,083 shares of OMNICELL, INC. (OMCL) at $36.85 ($0.11M total) on 2026-08-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Njoku Nnamdi
Published Aug 18, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 8:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OMCL
Neutral
high confidence
Mentioned
$OMCL
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMCLNeutralLow
01

Why it matters

The filing documents an open-market sale by the company’s President and COO, executed under a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

02

Market read

Traders may log the transaction for sentiment monitoring, but there is no new fundamental information to drive a directional trade.

03

What to watch

The article provides no context on total insider holdings, prior sale frequency, or whether other executives are selling/buying around the same period.

Relevance 3/10Novelty 3/10Timing: Filed on 2026-08-18 after-hours; reflects sale executed 2026-08-17.

Background

This is an SEC Form 4 insider transaction disclosure for OMNICELL, Inc. (OMCL).

Company-level read

Ticker impact

$OMCLNeutralHigh confidence
Context

OMNICELL Form 4 shows President and COO Njoku Nnamdi sold 3,083 shares at $36.85 on 2026-08-17 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move from this filing alone; any impact is likely short-lived and sentiment-driven.

Evidence & confidence

The disclosure is a scheduled open-market sale under a pre-arranged 10b5-1 plan, with no accompanying operational, financial, or regulatory catalyst described.

Market effects

Minimal, as this is a single-company insider transaction with no sector-wide information.

None indicated.

None indicated.

Counterpoint

Even 10b5-1 sales can coincide with private views on near-term risk, so traders may still watch for follow-on disclosures or changes in trading patterns.

Key entities

  • OMNICELL, INC.

    Company whose insider transaction is disclosed via Form 4.

  • Njoku Nnamdi

    President and COO who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMCLMed

OMCL Falls 20.1% in a Month as Booking and Margin Risks Build

Omnicell (OMCL) shares fell 20.1% over four weeks. The company reported Q2 2026 adjusted EPS of $0.94, up 108.9% y/y, and revenue of $312.2M, up 7.4%. Omnicell raised 2026 non-GAAP EPS to $2.15-$2.30 and EBITDA to $175-$185M, but expects $6M incremental memory-chip costs, weaker product bookings ($425-$560M) and lower annual recurring revenue ($660-$680M).

$OMCLMedAI 8/10

Omnicell (OMCL) Stock Trades Down, Here Is Why

Omnicell (NASDAQ: OMCL) shares fell 9.9% after the company reported Q2 results that beat expectations but issued weaker guidance. Omnicell posted Q2 revenue of $312.2 million and adjusted EPS of $0.94. For Q3, it projected revenue of about $304 million, below estimates, and next-quarter EPS guidance missed consensus.

$OMCLHigh

OMNICELL, INC. (OMCL): Results of Operations and Financial Condition

OMNICELL, INC. (OMCL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contact: Omnicell, Inc. David Unger 4220 North Freeway Vice President, Investor Relations Fort Worth, TX 76137 ir@omnicell.com Omnicell Announces Second Quarter 2026 Financial Results Omnicell delivers solid second quarter 2026 financial results Updates full year 202